Intravenous Infusions (XGHA:IIL) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Intravenous Infusions's annualized Gross Profit for the quarter that ended in . 20 was GHS Mil. Intravenous Infusions's average Total Assets over the quarter that ended in . 20 was GHS 0 Mil. Therefore, Intravenous Infusions's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Intravenous Infusions Gross-Profit-to-Asset % Historical Data

The historical data trend for Intravenous Infusions's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Gross-Profit-to-Asset % Chart

Intravenous Infusions Annual Data

Trend

Gross-Profit-to-Asset %

Intravenous Infusions Semi-Annual Data

Gross-Profit-to-Asset %

Competitive Comparison of Intravenous Infusions's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Gross-Profit-to-Asset % falls into.

Intravenous Infusions Gross-Profit-to-Asset % Calculation

Intravenous Infusions's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Intravenous Infusions's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Intravenous Infusions Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.